PATIENT CENTRICITY IN ACTION
Ipsen reports data from pancreatic ductal adenocarcinoma trial
Ipsen NHS Study Published - IFOPA - International Fibrodysplasia Ossificans Progressiva Association
Ipsen Signs an Exclusive WW License Agreement with IRLAB for Mesdopetam to Treat Parkinson Disease
Ipsen to acquire exclusive rights to investigational ERK inhibitor as part of its existing research collaboration with AGV Discovery | Liberi Group
Limb Spasm Treatments for MS Patients Explored by Flex Pharma, Ipsen Biopharmaceuticals
Ipsen gets rights to failed Genfit NASH drug, now in Phase 3 for rare liver disease - MedCity News
Ipsen - Innovation for patient care - Ipsen
Leveraging external data in the design and analysis of clinical trials in neuro-oncology - The Lancet Oncology
Two Ipsen Clinical Trials Released on ClinicalTrials.gov
Clinical trials - Ipsen
Ipsen to acquire worldwide rights to pre-clinical stage oncology programme - PMLiVE
PharmaBoardroom - Problems Pile Up at Ipsen after Further Clinical Setback
Ipsen receives CRL for potential bone treatment
Ipsen on LinkedIn: Ipsen announces positive clinical trial findings in patients living with… | 23 comments
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
Ipsen Becomes First to Best Standard of Care in Metastatic PDAC | BioSpace
Discover Ipsen new clinical trials section - Ipsen
How technology can improve the future of clinical trials - Pf Media
Now Recruiting: Carcinoid Syndrome Patients to Participate in Clinical Trial - Carcinoid Cancer Foundation
Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy | Business Wire
Irlab's Ipsen-partnered Parkinson's drug flunks phase 2 trial
Ipsen Pharma - Pharmaceutical Companies Database - ICH GCP
How the FDA Stifles New Cures, Part II: 90% of Clinical Trial Costs are Incurred in Phase III
Lauren Watson - Associate Director - Records Management - Data Management, Standards and Systems - Ipsen | LinkedIn
Bola Makanjuola, B.Pharm, CCRP - Neuroscience Account Specialist - Ipsen | LinkedIn
